Summary
Machine-generated summaryThe HUS Group in Finland held a procurement for radioactive seeds used to localize breast cancer. The procurement was divided into four lots covering seeds and needles supplied separately or preloaded, with activities of 0.1 mCi and 0.2 mCi. The estimated value was approximately EUR 900 000 to 1 100 000 excluding VAT. The contract has been awarded to MoMedico ApS and BXTAccelyon Ltd with an awarded value of EUR 1 100 000, which is at the top of the estimate. The agreement period is two years and may be extended by an option period of 1 + 1 years. Suppliers could tender for one or more lots.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 13 hours ago
More from this buyer
Full buyer profile1 open tender right now
- Family Pedigree Software Solution 23 days left
Recent awards
- Services provided by medical laboratories - HUS 596-2025 Large somatic gene panels
- Medical equipments, pharmaceuticals and personal care products - Immunoglobulin (IG) and T-cell receptor (TCR) clonality assays, IGHV somatic hypermutation assay and controls for IG/TCR assays
- Software package and information systems - 3D modelling tool for oral and maxillofacial surgery
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €11,311,844
- Buyer track record on Aperlena
- 29 notices tracked · 8 awarded
- €4,129,470 in awarded contracts
Never miss a tender like this
34 new notices in Medical equipment & pharmaceuticals in Finland in the last 7 days. Get an email when new ones appear. Free.
Set up my alert